Allogeneic marrow transplantation for chronic granulocytic leukemia

Blut. 1982 Oct;45(4):237-42. doi: 10.1007/BF00320190.

Abstract

Six patients with Philadelphia-chromosome (Ph' +)-positive chronic granulocytic leukemia were transplanted from their HLA-identical siblings after conditioning with cyclophosphamide and 1'000 rad total body irradiation. All received cyclosporin-A for prophylaxis of Graft-versus-Host disease. All patients showed prompt engraftment and all are cytogenetically and clinically in complete remission. Two patients had transient mild signs of Graft-versus-Host-disease and one patient had unilateral facial nerve paresis of unknown origin. All are ambulatory and well 6-18 months (median 10 months) after transplantation.

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow Transplantation*
  • Chromosomes, Human, 21-22 and Y
  • Cyclophosphamide / therapeutic use
  • Cyclosporins / therapeutic use
  • Female
  • Graft vs Host Reaction
  • HLA Antigens / analysis
  • Humans
  • Leukemia, Myeloid / therapy*
  • Male
  • Transplantation, Homologous
  • Whole-Body Irradiation

Substances

  • Cyclosporins
  • HLA Antigens
  • Cyclophosphamide